Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Samsung Medical Center
Samsung Medical Center
Centre Hospitalier Universitaire de Liege
Harvard School of Public Health (HSPH)
Kuwait University
Shanghai 10th People's Hospital
Mansoura University
Post Graduate Institute of Medical Education and Research, Chandigarh
Case Comprehensive Cancer Center
Canadian Network for Observational Drug Effect Studies, CNODES
Novo Nordisk A/S
GlaxoSmithKline
Mayo Clinic
Odense University Hospital